PharmaTech

JULY 26, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in the manufacturing space from a CDMO and a cell/gene therapy perspective.

52

52

PharmaTech

MARCH 2, 2023

In this episode of the Drug Digest episode, Grant Playter, associate editor, speaks with computer validation experts on how to set data controls and why efforts spent here are financially rewarding in the long run.

52

52

PharmaTech

MAY 4, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss the advantages and savings that continuous manufacturing may offer as well as the very real obstacles that might make a fully continuous process not feasible, especially in biologics manufacturing.

52

52

PharmaTech

MAY 24, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in early phase development, the role of CDMOs, and highlight the benefits and challenges of the outsourcing process.

52

52

PharmaTech

SEPTEMBER 27, 2023

In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, discusses small-molecule APIs, excipients, and formulation advances, including a discussion about novel approaches and solutions to pediatric formulations and taste-masking, a rundown of the fundamental stages of gaining a certificate of suitability (..)

52

52

PharmaTech

JULY 7, 2022

In this exclusive Drug Digest video, experts from Roche and MilliporeSigma divulge factors that could influence an organization to pursue specific biomolecules for development.

52

52

STAT

FEBRUARY 14, 2024

has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. Continue to STAT+ to read the full story…

327

327

PharmaTech

JANUARY 31, 2024

Below is a list of IPEC Guides and Position Papers that are available as FREE downloads from the IPEC-Americas website.

52

52

STAT

MAY 9, 2024

Meanwhile, here is the latest menu of tidbits for you to digest as you embark on your journey, which we hope is satisfying and rewarding. … Pfizer agreed to settle more than 10,000 cases accusing it of hiding cancer risks of its Zantac heartburn drug, Bloomberg News reports. Uptake of the drug has so far been slow.

244

244

STAT

NOVEMBER 30, 2022

The Food and Drug Administration approved the first therapy using bacteria from stool samples to treat a bowel disorder on Wednesday, paving the way for several similar treatments in development.    The drug, called Rebyota, is given as a one-dose treatment for clostridium difficile infection s, commonly known as C.

265

265

STAT

MARCH 25, 2024

Meanwhile, here is the latest menu of tidbits to digest. billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines , STAT wrties. Food and Drug Administration approved Wegovy for preventing heart problems in people with obesity and heart disease. Experts And of course, do stay in touch.

Diabetes 255

Diabetes 255

PharmaTech

FEBRUARY 29, 2024

This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma industry.

52

52

STAT

DECEMBER 2, 2022

Proteins help people move, digest food, and fight infections — to name a few of their numerous functions. They’re also the basis of a nearly  $300 billion  drug industry for treating cancer, immune diseases, and other conditions. Most of these therapies are only slightly altered versions of natural proteins.

Immunity 243

Immunity Immunization 243

World Pharma News

FEBRUARY 20, 2024

Any drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line the GI tract help with this process, but for many drugs, it’s unknown which of those transporters they use to exit the digestive tract.

84

84

STAT

APRIL 11, 2024

Meanwhile, here is the latest menu of tidbits for you to digest. Medicare actuaries expect the drug, which is called Leqembi and sold by Eisai in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024. The number of ongoing and active drug shortages in the U.S. We appreciate your insights.

Chemotherapy 227

Chemotherapy Immunity Immunization 227

STAT

MARCH 18, 2024

Meanwhile, here is the latest menu of tidbits for you to digest. Food and Drug Administration panel voted in favor of expanding use of CAR-T therapy in blood cancer, despite concerns about side effects , STAT writes. And as we fire up the coffee kettle, we are reaching for our flavor of the day, chocolate raspberry. … A U.S.

209

209

Pharmaceutical Technology

SEPTEMBER 6, 2023

Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.

52

52

STAT

FEBRUARY 12, 2024

Meanwhile, here are a few tidbits to digest. We accept all manner of confidential communications and secret dossiers … New diabetes and weight loss drugs may benefit patients undergoing hip replacement without adding to complication risks , Reuters reports, citing preliminary data released at a meeting of orthopedic surgeons.

Diabetes 223

Diabetes Vaccines Communication Hospitals 223

Safe Biologics

APRIL 11, 2023

On March 5th-6th, ASBM Chairman Ralph McKibbin, MD, FACP, FACG, AGAF participated in the 33rd annual Digestive Disease National Coalition public policy forum in Washington, DC March 5th and 6th. This year’s theme was “Improving Patient Care.” This year’s theme was “Improving Patient Care.”

Diabetes 100

Diabetes 100

PharmaTech

DECEMBER 6, 2022

Pharmaceutical Technology editors interview an automation expert from Automata on the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes.

52

52

STAT

APRIL 6, 2023

You can digest the results if you scroll down the screen. … A major obstacle looms for the drugs of the future – not enough doctors know how to administer them , The Wall Street Journal writes. Meanwhile, we hope you have a meaningful and productive journey today. And of course, do keep in touch.

Packaging 228

Packaging Immunity Immunization 228

STAT

APRIL 9, 2024

Meanwhile, here is the latest menu of tidbits for you to digest as you embark on your journey, which we hope is satisfying and rewarding. Food and Drug Administration and other regulatory agencies and file for an expanded approval of the vaccine, which is currently approved in the U.S., Our choice today is orange cream.

Vaccines 179

Vaccines 179

European Pharmaceutical Review

OCTOBER 13, 2022

The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. Traditionally, delivering protein drugs orally has been challenging. The capsule is also coated with small studs that brush mucus away.

135

135

PharmaTech

FEBRUARY 21, 2024

Lipid-based formulations (LBFs) are complex mixtures of lipid, surfactant and solvent excipient, where the composition determines the potential impact of dispersion and digestion on drug solubilization.

Drug Development 52

Drug Development 52

STAT

FEBRUARY 21, 2023

Meanwhile, here is the latest list of interesting items for you to digest. At issue are copay accumulators, which insurers use to blunt copay assistance offered by drug companies. So time to give it a nudge in a better direction with a cup of delicious stimulation. Our choice today is an old standby, hazelnut creme.

Pharmaceutical Companies 235

Pharmaceutical Companies Pharmaceutical Companies 235

STAT

NOVEMBER 7, 2023

A final recommendation will not be released until the agency has digested public comments. ” The asthma and skin drug has since become Sanofi’s biggest seller. But if the current recommendation is finalized, anyone with the disease will not have access going forward.

Communication 196

Communication 196

PharmaTech

OCTOBER 5, 2022

Pharmaceutical Technology editors interview oral solid dosage development experts from Syntegon and Colorcon, with discussions centered on continuous OSD production, containment safety, and authentication at the dose level.

Dosage 52

Dosage 52

The Thyroid Pharmacist

NOVEMBER 3, 2023

A more serious form of reflux, known as Gastroesophageal Reflux Disease (GERD), is one of the most common digestive disorders that is diagnosed. Slow gut motility: Slow motility (impaired digestion and slow movement of food through the GI tract) may cause acid reflux. Over time, this can diminish digestive function.

Immunity 96

Immunity Immunization Dosage Mayo Clinic 96

The Thyroid Pharmacist

DECEMBER 15, 2023

This supplement was betaine with pepsin — an enzyme used to support protein digestion. 3] Small intestinal bacterial overgrowth (SIBO) – Without stomach acid, which keeps them at bay, bacteria in the small intestine may grow and thrive on poorly digested proteins. My co-workers commented on my good mood at work.

Immunity 98

Immunity Immunization Dosage 98

PharmaTech

SEPTEMBER 29, 2022

Thursday, September 28, 2022 at 11am ET | 10am CT | 8am PT Learn the key benefits of continuous OSD production as well as the importance of authenticating OSD products at the dose-level with experts from Syntegon and Colorcon in this episode of the PharmTech Drug Digest Video Series.

52

52

PharmaTech

JUNE 29, 2022

Thursday June 30, 2022 at 11am ET | 10am CT | 8am PT Cell and gene therapy (CGT) and antibody-drug conjugate (ADC) developers and manufacturers discuss factors that could influence organizations to pursue specific biomolecules for development.

52

52

Pharmaceutical Technology

APRIL 5, 2023

On the same day, the Cystic Fibrosis Foundation announced the funding for Anagram under its venture philanthropy model designed to provide financial support to “de-risk CF drug discovery and development”. If trials are successful, Anagram’s therapy will reduce the number of enzyme pills patients need to take with meals to help digest food.

52

52

European Pharmaceutical Review

OCTOBER 17, 2022

and Parkinson’s UK’s drug development and discovery division, Parkinson’s Virtual Biotech , will collaborate on a new Phase II trial to study the effects of the drug ENT-01 on Parkinson’s Disease (PD)-associated dementia. . The drug ENT-01 helps to inhibit ?S US biopharma company Enterin Inc. Given orally, ENT-01 targets

Drug Development 86

Drug Development 86

FDA Law Blog: Biosimilars

FEBRUARY 21, 2024

CVM invited the public and stakeholders to comment on FDA’s regulation of animal foods with certain types of claims, that under the now withdrawn PPM, would be considered drug claims. In the absence of the policy, there seems a chance that CVM will recognize that certain claims such as production claims are not drug claims. 6687 and S.

52

52

Fusion Pharmacy

JANUARY 4, 2024

You may have also come across the phrase “the feel good drug” in reference to serotonin. It helps in governing your mood, memory, behavior, gastrointestinal balance, digestion, sleep, bone health, blood clotting, and sexual function, among other things. In medical terminology, you may know it as 5-hydroxytryptamine.

98

98

Pharmaceutical Technology

JUNE 10, 2023

According to GlobalData, Phase II drugs for Chondrosarcoma does not have sufficient historical data to build an indication benchmark PTSR for Phase II. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the TAS-117 LoA Report. Buy the report here. It is a small molecule administered by orally.

Drug Development 40

Drug Development 40

Pharmaceutical Technology

JUNE 10, 2023

According to GlobalData, Phase II drugs for Chondrosarcoma does not have sufficient historical data to build an indication benchmark PTSR for Phase II. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the TAS-117 LoA Report. Buy the report here. It is a small molecule administered by orally.

Drug Development 40

Drug Development 40